Integrin-based therapeutics: biological basis, clinical use and new drugs
K Ley, J Rivera-Nieves, WJ Sandborn… - Nature reviews Drug …, 2016 - nature.com
Integrins are activatable molecules that are involved in adhesion and signalling. Of the 24
known human integrins, 3 are currently targeted therapeutically by monoclonal antibodies …
known human integrins, 3 are currently targeted therapeutically by monoclonal antibodies …
Integrins as therapeutic targets: lessons and opportunities
The integrins are a large family of cell adhesion molecules that are essential for the
regulation of cell growth and function. The identification of key roles for integrins in a diverse …
regulation of cell growth and function. The identification of key roles for integrins in a diverse …
Integrins as therapeutic targets: successes and cancers
S Raab-Westphal, JF Marshall, SL Goodman - Cancers, 2017 - mdpi.com
Integrins are transmembrane receptors that are central to the biology of many human
pathologies. Classically mediating cell-extracellular matrix and cell-cell interaction, and with …
pathologies. Classically mediating cell-extracellular matrix and cell-cell interaction, and with …
[HTML][HTML] Drug-induced immune thrombocytopenia: pathogenesis, diagnosis, and management
RH Aster, BR Curtis, JG McFarland… - Journal of Thrombosis and …, 2009 - Elsevier
Drug-induced immune thrombocytopenia (DITP) can be triggered by a wide range of
medications. Although many cases of DITP are mild, some are characterized by life …
medications. Although many cases of DITP are mild, some are characterized by life …
Integrin αIIbβ3
K Bledzka, J Qin, EF Plow - Platelets, 2019 - Elsevier
Platelet aggregation is a critical event in thrombus formation and thus has extensive
involvement in physiological and pathological processes. The aggregation response …
involvement in physiological and pathological processes. The aggregation response …
Approach to the diagnosis and management of drug-induced immune thrombocytopenia
Drug-induced immune thrombocytopenia (DITP) is a challenging clinical problem that is
under-recognized, difficult to diagnose and associated with severe bleeding complications …
under-recognized, difficult to diagnose and associated with severe bleeding complications …
Anti-integrin monoclonal antibodies
Anti-integrin monoclonal antibodies | Journal of Cell Science | The Company of Biologists Skip
to Main Content Advertisement The Company of Biologists logo The Company of Biologists …
to Main Content Advertisement The Company of Biologists logo The Company of Biologists …
Hantavirus regulation of endothelial cell functions
ER Mackow, IN Gavrilovskaya - Thrombosis and haemostasis, 2009 - thieme-connect.com
Hantaviruses cause two vascular permeability-based diseases and primarily infect
endothelial cells which form the primary fluid barrier of the vasculature. Since hantavirus …
endothelial cells which form the primary fluid barrier of the vasculature. Since hantavirus …
A specialized integrin-binding motif enables proTGF-β2 activation by integrin αVβ6 but not αVβ8
VQ Le, B Zhao, S Ramesh, C Toohey… - Proceedings of the …, 2023 - National Acad Sciences
Activation of latent transforming growth factor (TGF)-β2 is incompletely understood. Unlike
TGF-β1 and β3, the TGF-β2 prodomain lacks a seven-residue RGDLXX (L/I) integrin …
TGF-β1 and β3, the TGF-β2 prodomain lacks a seven-residue RGDLXX (L/I) integrin …
GPIIb/IIIa inhibitors: from bench to bedside and back to bench again
PC Armstrong, K Peter - Thrombosis and haemostasis, 2012 - thieme-connect.com
From the discovery of the platelet glycoprotein (GP) IIb/IIIa and identification of its central role
in haemostasis, the integrin GPIIb/IIIa (αIIbβ3, CD41/CD61) was destined to be an anti …
in haemostasis, the integrin GPIIb/IIIa (αIIbβ3, CD41/CD61) was destined to be an anti …